Clinical trial / 2013
Alternate day fasting lowered weight, fat mass, and triacylglycerol in non-obese adults.
In a 12-week trial, 32 normal-weight and overweight adults were assigned to alternate day fasting or a control group. Alternate day fasting reduced body weight by 5.2 ± 0.9 kg and fat mass by 3.6 ± 0.7 kg relative to controls (both P < 0.001). The fasting group also experienced decreases in triacylglycerols (-20 ± 8%) and CRP (-13 ± 17%), while LDL cholesterol, HDL cholesterol, and resistin remained unchanged.
- Study type
- Randomized controlled trial
- Who was studied
- 32 normal-weight and overweight adults (BMI 20-29.9 kg/m2)
- What was measured
- body weight and cardiovascular risk markers
THE PAPER
Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial.
Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, Hoddy KK, Calvo Y. Nutr J, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.